1436
F. Schweizer et al.
LETTER
1
Table Characteristic H NMR- (360 MHz, CDCl3, rt, TMS) and high resolution
MS-data (HRMS) for the compounds 8,10-14.
80.5, 80.5, 74.8, 71.0 (C-4, C-5, C-6, C-7), 38.3 (C-2). IR
References and Notes
(CH2Cl2): 1798, 1674, 1199, 1099 cm-1. HRMS (ES,
(1) Varki, A. Glycobiology 1993, 3, 97.
[M+Na]+) calc. 706.27807, found 706.27842.
(2) a) Hirschmann, R.; Nicolaou, K.C.; Pietranico, S.; Leahy,
E.M.; Salvino, J.; Arison, B.; Cichy, M.A.; Spoors, P.G.;
Shakespeare, F.W.C.; Sprengeler, P.A. et al. J. Am. Chem.
Soc. 1993, 115, 12550 b) Hirschmann, R.; Hynes, J.J.; Cichy-
Knight, M.A.; van Rijn, R.D.; Sprengeler, P.A.; Spoors, P.G.;
Shakespeare, W.C.; Pietranico-Cole, S.; Barbosa, J.; Liu, J. et
al. J. Med. Chem. 1998, 41, 1382
(3) a) Graf von Roedern, E.; Kessler, H. Angew. Chem. Int. Ed.
Engl. 1994, 33, 670 b) Graf von Roedern, E.; Lohof, E.;
Hessler, G.; Hoffmann, M.; Kessler, H. J. Am. Chem. Soc.
1996, 118, 10156 c) Chakraborty, T.K.; Jayaprakash, S.;
Diwan, P.V.; Nagaraj, R.; Jampani, S.R.B.; Kunwar, A.C. J.
Am. Chem. Soc. 1998, 120, 12962.
(4) a) Drouillat, B.; Kellam, B.; Dekany, G.; Starr, M.S.; Toth, I.
Bioorg. Med. Chem. Lett. 1997, 7, 2247 b) Lohof, E.; Planker,
E.; Mang, C.; Burkhart, F.; Dechantsreiter, M.A.; Haubner,
R.; Wester, H-J. Schwaiger, M.; Hölzemann, G.; Goodman,
S.L.; Kessler, H. Angew. Chem. Int. Ed. 2000, 39, 2761.
(5) Goldstein, I.J.; Poretz, R.D. In The Lectins; Liener, I.E.;
Sharon, N.; Goldstein, I.J., Eds.; Academic Press: London
1986; p 35.
(6) Liang, R.; Yan. L.; Loebach, J.; Ge, M.; Uozumi, Y.;
Sekanina, K.; Horan, N.; Gildersleeve, J.; Thompson, C.;
Smith, A.; Biswas, K.; Still, W.C.; Kahne, D. Science 1996,
274, 1520.
(11) a) Ritter, J.J.; Minieri, P.P. J. Am. Chem. Soc. 1948, 70, 4045
b) Krimen, L.J.; Cota, D.J. Org. React. 1969, 17, 213.
(12) Ratcliffe, A.J.; Konradsson, P.; Fraser-Reid, B. J. Am. Chem.
Soc. 1990, 112, 5665.
(13) Dihydrooxazinones have been previously observed and were
used to synthesize -peptides: a) Podlech, J.; Seebach, D.
Angew. Chem. Int. Ed. Engl. 1995, 34, 471 b) Drey, C.N.C.;
Mietwa, E. J. Chem. Soc. Perkin Trans., 1 1982, 1587.
(14) Bothner-By, A.A.; Stephens, R.L.; Lee, J.; Warren, C.D.;
Jeanloz, R.W. J. Am. Chem. Soc. 1984, 106, 811.
(15) Hwang, T.-L.; Shaka, A.J. J. Magn. Reson. Ser. B 1993, 102,
155.
(16) Geen, H.; Freeman, R. J. Magn. Reson. 1991, 93, 93-141.
(17) Characteristic data for compound 15: 1H NMR (360 MHz,
CDCl3, r.t., TMS): = 3.96 (dd, 3J(H6,H7) = 1.2 Hz,
3J(H5,H6) = 2.8 Hz, 1H, H-6), 3.83 (d,3J(H4,H5) = 9.8 Hz, 1H,
H-4), 2.1-2.0 (s, br., 2H, NH2).
(18) Attempted acylation of the amine 15 was performed with 3
equiv of a 1:1 mixture containing 1-hydroxybenzotriazole and
Fmoc-L-Ala-OPfp in a 1:1 mixture of DMF and CH2Cl2 over
a period of 48 hours. No product formation was observed and
the ketose 16 was isolated after aqueous work up and
chromatography.
(19) Koert, U. Angew. Chem. Int. Ed. Engl. 1997, 36, 1836.
(20) Typical procedure for the one pot synthesis of a sugar
-
(7) Terrett, N.K.; Gardner, M.; Gordon, D.W.; Kobylecki, R.J.;
Steele, J. Tetrahedron 1995, 51, 8135.
peptide: Ketol 5 (0.1 mmol) was dissolved in 1:1 mixture
containing trifluoroacetic acid and dichloromethane (4 mL) at
0 C for 90 min. The solvent was removed under reduced
pressure and codistilled with toluene (2 10 mL) to dryness.
The oily residue was redissolved in dichloromethane (2 mLl)
trimethylsilyl trifluoromethanesulfonate (0.35 mmol) and
nitrile (1 mmol) were added at 0 C. After 90 min. the amine
component (1 mmol) was added and the reaction was stirred
for an additional 90 min at 0 C. Aqueous work up with sodium
bicarbonate followed by chromatographic purification
afforded the sugar -peptide in 60-70% yield.
(8) Overkleeft, H.S.; van Wiltenburg, J.; Pandit, U.K.
Tetrahedron 1994, 50, 4215.
(9) Characteristic data for compound 4: 1H NMR (360 MHz,
CDCl3, r.t., TMS): = 5.43 (s, br., 1H, OH), 4.00 (dd,
3J(H6,H7) = 1.2 Hz, 3J(H5,H6) = 2.8 Hz, 1H, H-6), 3.75 (d,
3J(H4,H5) = 9.8 Hz, 1H, H-4).
(10) Characteristic data for compound 7: 1H NMR (360 MHz,
CDCl3, r.t., TMS): = 4.67 (ddd, 3J(H6,H7) ~ 1 Hz,
3J(H7,H8a) = 7.9 Hz, 3J(H7,H8b) = 5.5 Hz, 1H, H-7), 4.12 (dd,
3J(H5,H6) = 2.4 Hz, 1H, H-6), 4.06 (dd, 3J(H4,H5) = 9.9 Hz,
1H, H-5), 4.02 (d, 1H, H-4), 3.65 (dd, 2J(H8a,H8b) = 9.1 Hz,
1H, H-8a), 3.56 (dd, 1H, H-8b), 2.89 (d, 2J(H2a,H2b) = 16.3 Hz,
1H, H-2a), 2.73 (d, 1H, H-2b). 13C NMR (75 MHz, CDCl3,
25 C, TMS): = 164.9 (C=O), 152.3 (C=N), 88.9 (C-3),
Article Identifier:
1437-2096,E;2001,0,09,1434,1436,ftx,en;S03001ST.pdf
Synlett 2001, No. 9, 1434–1436 ISSN 0936-5214 © Thieme Stuttgart · New York